Valneva SE (VALN) Notes Payables (2020 - 2023)
Valneva SE (VALN) posted quarterly Notes Payables of $16.1 million for Q1 2023, up 20.69% year-on-year from $13.3 million in Q1 2022, and up 22.25% on a QoQ basis from $13.2 million in Q4 2022.
Valneva SE (VALN) Notes Payables (2020 - 2023) Analysis & Trends
Valneva SE (VALN) has reported Notes Payables for 4 consecutive years, with $16.1 million the latest figure, recorded in Q1 2023.
- Quarterly Notes Payables rose 20.69% year-over-year to $16.1 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $16.1 million (up 20.69% YoY) and the FY2022 annual result came in at $13.2 million, up 62.94% from the prior year.
- Notes Payables climbed to $16.1 million in Q1 2023 per VALN's latest filing, from $13.2 million in the prior quarter.
- Over the last five years, Notes Payables for VALN reached as high as $16.1 million in Q1 2023 and fell as low as $8.0 million in Q4 2020.
- A 4-year average of $12.3 million and a median of $13.2 million in 2022 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2021 — Notes Payables rose 1.7% — and 2022, when it surged 62.94%.
- Year by year, Notes Payables stood at $8.0 million in 2020, then increased by 1.7% to $8.1 million in 2021, then soared by 62.94% to $13.2 million in 2022, then grew by 22.25% to $16.1 million in 2023.
- According to Business Quant data, Notes Payables over the past three periods registered $16.1 million, $13.2 million, and $14.2 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 16.11 Mn |
| Dec 31, 2022 | 13.18 Mn |
| Sep 30, 2022 | 14.22 Mn |
| Jun 30, 2022 | 13.14 Mn |
| Mar 31, 2022 | 13.35 Mn |
| Dec 31, 2021 | 8.09 Mn |
| Dec 31, 2020 | 7.95 Mn |